AHMADSHAH MIRKHEL

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology FAIRFAX, VA NPI 1790729317

General Payments — all program years on this page

$1,778.12

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $493.53 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $493.5321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $80.604
2019 $321.479
2020 $119.655
2021 $15.951
2022 $332.3114
2023 $414.6120
2024 $493.5321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082023594 CorMedix Inc. $29.81 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110260 Novartis Pharmaceuticals Corporation $21.11 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110268 Novartis Pharmaceuticals Corporation $17.55 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110280 Novartis Pharmaceuticals Corporation $23.94 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110284 Novartis Pharmaceuticals Corporation $24.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110286 Novartis Pharmaceuticals Corporation $26.39 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087110290 Novartis Pharmaceuticals Corporation $17.70 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091136669 ANI Pharmaceuticals, Inc. $29.21 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091144714 ANI Pharmaceuticals, Inc. $24.76 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105508560 AstraZeneca Pharmaceuticals LP $21.06 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115999090 GlaxoSmithKline, LLC. $28.25 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117329824 Amgen Inc. $34.40 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118943861 Otsuka America Pharmaceutical, Inc. $25.18 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132275343 SCPHARMACEUTICALS INC. $17.32 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145108480 Mallinckrodt Hospital Products Inc. $32.24 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145824362 AKEBIA THERAPEUTICS INC $27.81 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146695932 Ardelyx, Inc. $25.13 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149882816 Travere Therapeutics, Inc. $6.87 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150687607 Aurinia Pharma U.S., Inc. $27.82 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154201750 Fresenius USA Marketing, Inc. $13.83 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154201752 Fresenius USA Marketing, Inc. $18.22 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.